{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:06:20Z","timestamp":1784797580832,"version":"3.55.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T00:00:00Z","timestamp":1680393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.critrevonc.2023.103982","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T15:30:47Z","timestamp":1680276647000},"page":"103982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Poor-prognosis molecular subtypes in adenocarcinomas of pancreato-biliary and gynecological origin: A systematic review"],"prefix":"10.1016","volume":"185","author":[{"given":"Marjolein F.","family":"Lansbergen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Khelil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faridi S. van","family":"Etten \u2013 Jamaludin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten F.","family":"Bijlsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke W.M.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2023.103982_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103428","article-title":"The recurring features of molecular subtypes in distinct gastrointestinal malignancies\u2014A systematic review","volume":"164","author":"Adam","year":"2021","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"21","key":"10.1016\/j.critrevonc.2023.103982_bib2","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation\u2013positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"7592","key":"10.1016\/j.critrevonc.2023.103982_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103982_bib4","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/ph14090898","article-title":"RTK25: a comprehensive molecular profiling strategy in cholangiocarcinoma using an integrated bioinformatics approach","volume":"14","author":"Balasubramanian","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"7391","key":"10.1016\/j.critrevonc.2023.103982_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"Barretina","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103982_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/modpathol.3800401","article-title":"DeltaNp63 expression in pancreas and pancreatic neoplasia","volume":"18","author":"Basturk","year":"2005","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103982_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nrgastro.2017.33","article-title":"Molecular subtypes in cancers of the gastrointestinal tract","volume":"14","author":"Bijlsma","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103982_bib8","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1158\/1078-0432.CCR-20-1039","article-title":"Transcriptomic analysis of laser capture microdissected tumors reveals cancer-and stromal-specific molecular subtypes of pancreatic ductal adenocarcinoma","volume":"27","author":"Birnbaum","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00535-013-0767-4","article-title":"KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer","volume":"48","author":"Boeck","year":"2013","journal-title":"J. Gastroenterol."},{"issue":"13","key":"10.1016\/j.critrevonc.2023.103982_bib10","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1158\/0008-5472.CAN-07-6595","article-title":"A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer","volume":"68","author":"Bonome","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib11","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hep.29789","article-title":"cHCC\u2010CCA: consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation","volume":"68","author":"Brunt","year":"2018","journal-title":"Hepatology"},{"issue":"7353","key":"10.1016\/j.critrevonc.2023.103982_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2023.103982_bib13","unstructured":"Cancer Genome Atlas Research, N. , Albert Einstein College of, M. , Analytical Biological, S. , Barretos Cancer, H. , Baylor College of, M. , Beckman Research Institute of City of, H , Buck Institute for Research on , A., Canada's Michael Smith Genome Sciences, C , Harvard Medical , S., Helen, F.G.C.C., Research Institute at Christiana Care Health , S., HudsonAlpha Institute for, B., Ilsbio, L.L.C., Indiana University School of, M., Institute of Human , V., Institute for Systems, B , International Genomics, C , Leidos, B. , Massachusetts General, H , McDonnell Genome Institute at Washington, U , Medical College of, W , Medical University of South, C , Memorial Sloan Kettering Cancer, C , Montefiore Medical, C , NantOmics, National Cancer, I., National Hospital , A.N., National Human Genome Research, I , National Institute of Environmental Health , S., National Institute on, D , Other Communication, D , Ontario Tumour Bank, L.H.S.C , Ontario Tumour Bank , O.I.f.C.R., Ontario Tumour Bank , T.O.H., Oregon, H., Science, U , Samuel Oschin Comprehensive Cancer Institute, C.-S.M.C , International, S.R.A , St Joseph's Candler Health , S., Eli, Edythe, L.B.I.o.M.I.o.T., Harvard, U , Research Institute at Nationwide Children's, H , Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, U., University of, B., University of Texas , M.D.A.C.C., University of Abuja Teaching, H , University of Alabama at, B , University of California, I , University of California Santa, C , University of Kansas Medical, C , University of, L., University of New Mexico Health Sciences, C , University of North Carolina at Chapel, H , University of Oklahoma Health Sciences, C , University of, P., University of Sao Paulo , R.a.P.M.S., University of Southern, C., University of, W , University of Wisconsin School of, M., Public, H., Van Andel Research, I , Washington University in St, L , 2017. Integrated genomic and molecular characterization of cervical cancer. Nature 543(7645), 378\u2013384."},{"issue":"24","key":"10.1016\/j.critrevonc.2023.103982_bib14","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","article-title":"Cancer of the ovary","volume":"351","author":"Cannistra","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2012.23","article-title":"The biliary tree\u2014a reservoir of multipotent stem cells","volume":"9","author":"Cardinale","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"49","key":"10.1016\/j.critrevonc.2023.103982_bib16","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.1038\/sj.onc.1207979","article-title":"Gene expression profiling of advanced ovarian cancer: characterization of a molecular signature involving fibroblast growth factor 2","volume":"23","author":"Cecco","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2023.103982_bib17","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.e15291","article-title":"Targeting the CD44\/EMT phenotype for improving response to therapy in pancreatic cancer models","author":"Chang","year":"2015","journal-title":"Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103982_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","article-title":"Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution","volume":"52","author":"Chan-Seng-Yue","year":"2020","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103982_bib19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0015-0282(16)35940-4","article-title":"Electron microscopy of the human fallopian tube","volume":"17","author":"Clyman","year":"1966","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm.2344","article-title":"Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy","volume":"17","author":"Collisson","year":"2011","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103982_bib21","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.annonc.2021.07.004","article-title":"Updated treatment recommendations for newly diagnosed epithelial ovarian carcinoma from the ESMO Clinical Practice Guidelines","volume":"32","author":"Colombo","year":"2021","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103982_bib22","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103982_bib23","first-page":"494","article-title":"p63 expression profiles in human normal and tumor tissues","volume":"8","author":"Di Como","year":"2002","journal-title":"Clin. Cancer Res"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56826-9","article-title":"Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems","volume":"10","author":"Dijk","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2023.103982_bib25","article-title":"Critical appraisal of scientific articles","author":"Du Prel","year":"2009","journal-title":"a Ser. Eval. Sci. Publ. Dtsch. Arzteblatt Int. 106(7), 100"},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103982_bib26","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","article-title":"The cell of origin of ovarian epithelial tumours","volume":"9","author":"Dubeau","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2023.103982_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/cancers13040733","article-title":"Molecular classification and tumor microenvironment characterization of gallbladder cancer by comprehensive genomic and transcriptomic analysis","volume":"13","author":"Ebata","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.103982_bib28","article-title":"Computed tomography imaging-based radiogenomics analysis reveals hypoxia patterns and immunological characteristics in ovarian cancer","volume":"13","author":"Feng","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2023.103982_bib29","first-page":"2013","article-title":"curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome","author":"Ganzfried","year":"2013","journal-title":"Database"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103982_bib30","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann. Surg."},{"issue":"22","key":"10.1016\/j.critrevonc.2023.103982_bib31","doi-asserted-by":"crossref","first-page":"19070","DOI":"10.18632\/oncotarget.4233","article-title":"Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas","volume":"6","author":"Guti\u00e9rrez","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2023.103982_bib32","article-title":"Hmisc: harrel miscellaneous","volume":"4","author":"Harrel","year":"2022","journal-title":"R. Package Version"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103982_bib33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.14740\/jocmr4853","article-title":"Molecular histopathology for establishing diagnostic method and clinical therapy for ovarian carcinoma","volume":"15","author":"Hayashi","year":"2023","journal-title":"J. Clin. Med Res"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib34","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2023.103982_bib35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejca.2021.01.042","article-title":"Tumour and stroma RNA signatures predict more accurately distant recurrence than clinicopathological factors in resected pancreatic adenocarcinoma","volume":"148","author":"Hilmi","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103982_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2023.103982_bib37","first-page":"929","article-title":"Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin","volume":"158","author":"Hoadley","year":"2014"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103982_bib38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ccell.2020.01.003","article-title":"The repertoire of serous ovarian cancer non-genetic heterogeneity revealed by single-cell sequencing of normal fallopian tube epithelial cells","volume":"37","author":"Hu","year":"2020","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103982_bib39","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.surg.2012.12.005","article-title":"Recurrence after operative management of intrahepatic cholangiocarcinoma","volume":"153","author":"Hyder","year":"2013","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103982_bib40","doi-asserted-by":"crossref","first-page":"djx030","DOI":"10.1093\/jnci\/djx030","article-title":"Annual report to the nation on the status of cancer, 1975\u20132014, featuring survival. JNCI","volume":"109","author":"Jemal","year":"2017","journal-title":"J. Natl. Cancer Inst."},{"issue":"7677","key":"10.1016\/j.critrevonc.2023.103982_bib41","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature24269","article-title":"Transitional basal cells at the squamous\u2013columnar junction generate Barrett\u2019s oesophagus","volume":"550","author":"Jiang","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1541-7786.MCR-14-0076","article-title":"CD44 regulates pancreatic cancer invasion through MT1-MMP","volume":"13","author":"Jiang","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.103982_bib43","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fonc.2019.00246","article-title":"Pancreatic cancer heterogeneity can be explained beyond the genome","volume":"9","author":"Juiz","year":"2019","journal-title":"Front. Oncol."},{"issue":"SUPPL. 1","key":"10.1016\/j.critrevonc.2023.103982_bib44","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ygyno.2015.01.289","article-title":"Unique molecular portraits of ovarian cancer: Implications for prognostics and targeted therapeutics","volume":"137","author":"Khulpateea","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103982_bib45","first-page":"1","article-title":"Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer","volume":"13","author":"Kim","year":"2014","journal-title":"Biomed. Eng. Online"},{"issue":"14","key":"10.1016\/j.critrevonc.2023.103982_bib46","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1158\/1078-0432.CCR-16-2196","article-title":"Bevacizumab may differentially improve ovarian cancer outcome in patients with proliferative and mesenchymal molecular subtypes","volume":"23","author":"Kommoss","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.103982_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jnci\/dju249","article-title":"Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer","volume":"106","author":"Konecny","year":"2014","journal-title":"JNCI: J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2023.103982_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1067666","article-title":"Characterization of the microenvironment in different immune-metabolism subtypes of cervical cancer with prognostic significance","volume":"14","author":"Lai","year":"2023","journal-title":"Front Genet"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103982_bib49","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/path.4536","article-title":"Efficient molecular subtype classification of high\u2010grade serous ovarian cancer","volume":"236","author":"Leong","year":"2015","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib50","first-page":"280","article-title":"Epithelial ovarian cancer: evolution of management in the era of precision medicine","volume":"69","author":"Lheureux","year":"2019","journal-title":"CA: a Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s12876-022-02552-y","article-title":"Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma","volume":"22","author":"Li","year":"2022","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib52","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12935-022-02502-4","article-title":"Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer","volume":"22","author":"Liang","year":"2022","journal-title":"Cancer Cell Int"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib53","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/oxfordjournals.aje.a000179","article-title":"Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations","volume":"156","author":"Little","year":"2002","journal-title":"Am. J. Epidemiol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103982_bib54","doi-asserted-by":"crossref","first-page":"dju245","DOI":"10.1093\/jnci\/dju245","article-title":"Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma","volume":"106","author":"Liu","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103982_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109852","article-title":"Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancer","volume":"37","author":"Lodestijn","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103982_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12979","article-title":"Tumour microenvironment\u2010based molecular profiling reveals ideal candidates for high\u2010grade serous ovarian cancer immunotherapy","volume":"54","author":"Lu","year":"2021","journal-title":"Cell Prolif."},{"issue":"24","key":"10.1016\/j.critrevonc.2023.103982_bib57","doi-asserted-by":"crossref","first-page":"10069","DOI":"10.1073\/pnas.0703900104","article-title":"Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers","volume":"104","author":"Mani","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib58","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib59","first-page":"1444","volume":"1864","author":"Marin","year":"2018","journal-title":"Chemoresistance chemosensitization cholangiocarcinoma. Biochim. Et. Biophys. Acta (BBA)-Mol. Basis Dis."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103982_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.140","article-title":"Proliferation and tissue remodeling in cancer: the hallmarks revisited","volume":"3","author":"Markert","year":"2012","journal-title":"Cell death Dis."},{"issue":"2B","key":"10.1016\/j.critrevonc.2023.103982_bib61","first-page":"771","article-title":"Cytokeratin 17 and p63 are markers of the HPV target cell, the cervical stem cell","volume":"24","author":"Martens","year":"2004","journal-title":"Anticancer Res."},{"key":"10.1016\/j.critrevonc.2023.103982_bib62","article-title":"Discovery and 3D imaging of a novel \u0394Np63-expressing basal cell type in human pancreatic ducts with implications in disease","author":"Martens","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2023.103982_bib63","article-title":"Discovery and 3D imaging of a novel DeltaNp63-expressing basal cell type in human pancreatic ducts with implications in disease","author":"Martens","year":"2021","journal-title":"Gut"},{"issue":"1 SUPPL","key":"10.1016\/j.critrevonc.2023.103982_bib64","first-page":"359A","article-title":"Integrative stroma-tumor-immune-based classification of intrahepatic cholangiocarcinoma identifies novel microenvironment profiles","volume":"72","author":"Martin","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103982_bib65","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/gutjnl-2018-317706","article-title":"Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes","volume":"68","author":"Maurer","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.critrevonc.2023.103982_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1104514","article-title":"Investigating the suitability of in vitro cell lines as models for the major subtypes of epithelial ovarian cancer","volume":"11","author":"McCabe","year":"2023","journal-title":"Front Cell Dev. Biol."},{"issue":"SUPPL. 1","key":"10.1016\/j.critrevonc.2023.103982_bib67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ygyno.2016.04.498","article-title":"Gene expression profiling of 389 endometrioid endometrial carcinomas reveals 4 distinct molecular subtypes","volume":"141","author":"McClung","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103982_bib68","first-page":"939","volume":"29","author":"Meng","year":"2012","journal-title":"CD44+\/CD24\u2212 ovarian Cancer Cells Demonstr. Cancer stem Cell Prop. Correl. Surviv. Clin. Exp. Metastas-.-."},{"key":"10.1016\/j.critrevonc.2023.103982_bib69","first-page":"1","article-title":"Parkinson\u2019s disease subtypes: critical appraisal and recommendations","author":"Mestre","year":"2021","journal-title":"J. Park. 'S. Dis. (Prepr. )"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103982_bib70","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2017.01.010","article-title":"Mixed hepatocellular cholangiocarcinoma tumors: cholangiolocellular carcinoma is a distinct molecular entity","volume":"66","author":"Moeini","year":"2017","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103982_bib71","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/ng.3398","article-title":"Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma","volume":"47","author":"Moffitt","year":"2015","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103982_bib72","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","article-title":"Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma","volume":"73","author":"Montal","year":"2020","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103982_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002888","article-title":"Generation of breast cancer stem cells through epithelial-mesenchymal transition","volume":"3","author":"Morel","year":"2008","journal-title":"PloS One"},{"key":"10.1016\/j.critrevonc.2023.103982_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103749","article-title":"Prospects of targeting PI3K\/AKT\/mTOR pathway in pancreatic cancer","volume":"176","author":"Mortazavi","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103982_bib75","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ajpath.2015.12.029","article-title":"Establishment of a novel histopathological classification of high-grade serous ovarian carcinoma correlated with prognostically distinct gene expression subtypes","volume":"186","author":"Murakami","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103982_bib76","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrm4056","article-title":"Ovary and fimbrial stem cells: biology, niche and cancer origins","volume":"16","author":"Ng","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"Supplement 1","key":"10.1016\/j.critrevonc.2023.103982_bib77","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.pan.2020.07.392","article-title":"A Molecular Gradient as a universal classifier of pancreatic adenocarcinoma that predicts tumor aggressiveness and mFOLFIRINOX sensitivity","volume":"20","author":"Nicolle","year":"2020","journal-title":"Pancreatology"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103982_bib78","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/hep.25890","article-title":"Transcriptomic profiling reveals hepatic stem\u2010like gene signatures and interplay of miR\u2010200c and epithelial\u2010mesenchymal transition in intrahepatic cholangiocarcinoma","volume":"56","author":"Oishi","year":"2012","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.critrevonc.2023.103982_bib79","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1158\/1078-0432.CCR-19-3724","article-title":"GATA6 expression distinguishes classical and basal-like subtypes in advanced pancreatic cancer","volume":"26","author":"O'Kane","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.103982_bib80","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103982_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065144","article-title":"Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome","volume":"8","author":"Overman","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.critrevonc.2023.103982_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int. J. Surg."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103982_bib83","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/stem.1207","article-title":"Stem\u2010like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation","volume":"30","author":"Paik","year":"2012","journal-title":"Stem Cells"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103982_bib84","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.cgh.2009.07.039","article-title":"Desmoplasia of pancreatic ductal adenocarcinoma","volume":"7","author":"Pandol","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6797","key":"10.1016\/j.critrevonc.2023.103982_bib85","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"nature"},{"issue":"26","key":"10.1016\/j.critrevonc.2023.103982_bib86","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103982_bib87","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/ncb3025","article-title":"Mammary stem cells have myoepithelial cell properties","volume":"16","author":"Prater","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103982_bib88","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","article-title":"Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features","volume":"155","author":"Puleo","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2023.103982_bib89","unstructured":"R2: Genomics Analysis and Visualization Platform (http:\/\/r2.amc.nl). Amsterdam University Medical Centers, Center for Experimental Molecular Medicine, accessed on 17\u201311-2022."},{"issue":"25","key":"10.1016\/j.critrevonc.2023.103982_bib90","doi-asserted-by":"crossref","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","article-title":"Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer","volume":"184","author":"Raghavan","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib91","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib92","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/1078-0432.CCR-19-1467","article-title":"Purity independent subtyping of tumors (PurIST), a clinically robust, single-sample classifier for tumor subtyping in pancreatic cancer","volume":"26","author":"Rashid","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/cells10010045","article-title":"Pan-Cancer molecular patterns and biological implications associated with a tumor-specific molecular signature","volume":"10","author":"Rocha","year":"2020","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib94","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/cancers13040906","article-title":"The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features","volume":"13","author":"Romani","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib95","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1152\/physrev.1996.76.1.69","article-title":"Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction","volume":"76","author":"Ronnov-Jessen","year":"1996","journal-title":"Physiol. Rev."},{"issue":"17","key":"10.1016\/j.critrevonc.2023.103982_bib96","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3748\/wjg.v27.i17.1943","article-title":"BRCA mutated pancreatic cancer: A change is coming","volume":"27","author":"Rosen","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06000","article-title":"Unsupervised subtyping and methylation landscape of pancreatic ductal adenocarcinoma","volume":"7","author":"Roy","year":"2021","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103982_bib98","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/bjc.2011.219","article-title":"A seven-gene prognostic model for platinum-treated ovarian carcinomas","volume":"105","author":"Sabatier","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib99","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1158\/0008-5472.CAN-07-2017","article-title":"Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype","volume":"68","author":"Sarrio","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2023.103982_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.18.00096","article-title":"Platform-independent classification system to predict molecular subtypes of high-grade serous ovarian carcinoma","volume":"3","author":"Shilpi","year":"2019","journal-title":"JCO Clin. Cancer Inform."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103982_bib101","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","article-title":"Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes","volume":"144","author":"Sia","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.critrevonc.2023.103982_bib102","doi-asserted-by":"crossref","unstructured":"Siegel, R.L., Miller, K.D., Fuchs, H.E., Jemal, A., 2022. Cancer statistics, 2022. CA: a cancer journal for clinicians.","DOI":"10.3322\/caac.21708"},{"issue":"34","key":"10.1016\/j.critrevonc.2023.103982_bib103","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.1038\/onc.2010.215","article-title":"EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer","volume":"29","author":"Singh","year":"2010","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103982_bib104","first-page":"2397","article-title":"Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting. Hepatology (Baltimore","volume":"59","author":"Sirica","year":"2014","journal-title":"Md )"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103982_bib105","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.celrep.2018.10.051","article-title":"TP63-mediated enhancer reprogramming drives the squamous subtype of pancreatic ductal adenocarcinoma","volume":"25","author":"Somerville","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.critrevonc.2023.103982_bib106","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53381","article-title":"Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation","volume":"9","author":"Somerville","year":"2020","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib107","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40364-021-00260-5","article-title":"p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors","volume":"9","author":"Steurer","year":"2021","journal-title":"Biomark. Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103982_bib108","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib109","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12885-022-09487-3","article-title":"Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristics","volume":"22","author":"Tan","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2023.103982_bib110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ebiom.2019.11.017","article-title":"Analysis of gene expression signatures identifies prognostic and functionally distinct ovarian clear cell carcinoma subtypes","volume":"50","author":"Tan","year":"2019","journal-title":"EBioMedicine"},{"issue":"41","key":"10.1016\/j.critrevonc.2023.103982_bib111","doi-asserted-by":"crossref","first-page":"43843","DOI":"10.18632\/oncotarget.5983","article-title":"CSIOVDB: a microarray gene expression database of epithelial ovarian cancer subtype","volume":"6","author":"Tan","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103982_bib112","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/path.5191","article-title":"Decoding transcriptomic intra\u2010tumour heterogeneity to guide personalised medicine in ovarian cancer","volume":"247","author":"Tan","year":"2019","journal-title":"J. Pathol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103982_bib113","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/emmm.201201823","article-title":"Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer","volume":"5","author":"Tan","year":"2013","journal-title":"EMBO Mol. Med."},{"issue":"Pt 3","key":"10.1016\/j.critrevonc.2023.103982_bib114","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1242\/jcs.94.3.403","article-title":"Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium","volume":"94","author":"Taylor-Papadimitriou","year":"1989","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.critrevonc.2023.103982_bib115","unstructured":"Team, R.C., 2021. R: A language and environment for statistical computing., 4.1.2 ed., Vienna, Austria."},{"key":"10.1016\/j.critrevonc.2023.103982_bib116","article-title":"Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis","author":"Ten Hoorn","year":"2021","journal-title":"JNCI: J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103982_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245871","article-title":"CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression","volume":"16","author":"Thanee","year":"2021","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103982_bib118","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"16","key":"10.1016\/j.critrevonc.2023.103982_bib119","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103982_bib120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128066","article-title":"Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas","volume":"10","author":"Uehara","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2023.103982_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103465","article-title":"The potential targeted drugs for fusion genes including NRG1 in pancreatic cancer","volume":"166","author":"Umemoto","year":"2021","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2023.103982_bib122","first-page":"1","article-title":"Prognostically relevant gene signatures of high-grade serous ovarian carcinoma","volume":"123","author":"Verhaak","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"15","key":"10.1016\/j.critrevonc.2023.103982_bib123","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1158\/1078-0432.CCR-17-0246","article-title":"Pooled clustering of high-grade serous ovarian cancer gene expression leads to novel consensus subtypes associated with survival and surgical outcomes","volume":"23","author":"Wang","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103982_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203824","article-title":"Dissecting cancer heterogeneity based on dimension reduction of transcriptomic profiles using extreme learning machines","volume":"13","author":"Wang","year":"2018","journal-title":"Plos One"},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103982_bib125","first-page":"4097","article-title":"Comprehensive cross-population analysis of high-grade serous ovarian cancer supports no more than three subtypes. G3: Genes, Genomes","volume":"6","author":"Way","year":"2016","journal-title":"Genetics"},{"key":"10.1016\/j.critrevonc.2023.103982_bib126","first-page":"9","article-title":"Sample-Specific Perturbation of Gene Interactions Identifies Pancreatic Cancer Subtypes","volume":"23","author":"Wei","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2023.103982_bib127","series-title":"Matrix (version 0.92)","article-title":"R package 'corrplot': Visualization of a Correlation","author":"Wei","year":"2021"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ygyno.2016.02.023","article-title":"Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures","volume":"141","author":"Winterhoff","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"24 Supplement","key":"10.1016\/j.critrevonc.2023.103982_bib129","article-title":"Dysregulation of HNF1 B\/Clusterin axis enhances disease progression in a highly aggressive subset of pancreatic cancer","volume":"79","author":"Yang","year":"2019","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103982_bib130","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/1078-0432.CCR-11-2725","article-title":"High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway","volume":"18","author":"Yoshihara","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103982_bib131","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1158\/0008-5472.CAN-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Zhang","year":"2008","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib132","first-page":"1","article-title":"Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103982_bib133","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12885-018-4546-8","article-title":"Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes","volume":"18","author":"Zhao","year":"2018","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103982_bib134","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/1078-0432.CCR-18-3121","article-title":"Clinical and genomic implications of luminal and basal subtypes across carcinomas","volume":"25","author":"Zhao","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.103982_bib135","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3389\/fonc.2019.00802","article-title":"CD44 expression predicts prognosis of ovarian cancer patients through promoting epithelial-mesenchymal transition (EMT) by regulating Snail, ZEB1, and Caveolin-1","author":"Zhou","year":"2019","journal-title":"Front. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:49:06Z","timestamp":1760903346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842823000707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":135,"alternative-id":["S1040842823000707"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103982","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor-prognosis molecular subtypes in adenocarcinomas of pancreato-biliary and gynecological origin: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103982"}}